atropine has been researched along with thymoquinone in 1 studies
| Studies (atropine) | Trials (atropine) | Recent Studies (post-2010) (atropine) | Studies (thymoquinone) | Trials (thymoquinone) | Recent Studies (post-2010) (thymoquinone) |
|---|---|---|---|---|---|
| 26,711 | 1,259 | 1,697 | 1,092 | 3 | 888 |
| Protein | Taxonomy | atropine (IC50) | thymoquinone (IC50) |
|---|---|---|---|
| Caspase-1 | Homo sapiens (human) | 1.08 | |
| Serine/threonine-protein kinase PLK1 | Homo sapiens (human) | 2.18 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ali, SA; Meitei, KV | 1 |
1 other study(ies) available for atropine and thymoquinone
| Article | Year |
|---|---|
Nigella sativa seed extract and its bioactive compound thymoquinone: the new melanogens causing hyperpigmentation in the wall lizard melanophores.
Topics: Animals; Atropine; Benzoquinones; Cholinesterase Inhibitors; Dermatologic Agents; Hyperpigmentation; Hypopigmentation; Lizards; Melanins; Melanophores; Neostigmine; Nigella sativa; Plant Extracts; Scopolamine; Seeds; Skin; Sodium Chloride | 2011 |